Literature DB >> 31258603

Prediction of anastomotic leakage after anterior rectal resection.

Shubang Cheng1, Bolin He2, Xueyi Zeng3.   

Abstract

OBJECTIVE: Anastomotic Leakage (AL) is one of the most common complications after resection of rectal cancer. Recognition of the incidence and risk factors related to AL is important. This study aimed develops a model that can predict anastomotic leakage after anterior rectal resection.
METHODS: Data from 188 patients undergoing anterior resection of rectal cancer were collected for retrospective analysis. Patients were randomly divided in the development set and validation set at a 1:1 ratio. We first included age, sex, preoperative chemoradiotherapy, tumor size, degree of tumor differentiation, stage, TNM stage, lymph vascular invasion, distance, anastomotic method, diabetes, intraoperative time, intraoperative bleeding and smoking as candidates for variable selection with a LASSO method. A ROC curve was constructed with the validation set to assess the accuracy of the prediction model.
RESULTS: AL occurred in 20 of 188 patients (10.6%). Preoperative chemoradiotherapy (p=0.04), medium degree of tumor differentiation (p=0.04), anastomotic method (p<0.01), intraoperative bleeding≥400ml (p<0.01), smoking (p<0.01), diabetes (p<0.01) were significantly related to AL. The area under the ROC curve of the prediction model is 0.952.
CONCLUSIONS: This study developed a model that can predict anastomotic leakage after anterior rectal resection, which may aid the selection of preventive ileostomy and postoperative management.

Entities:  

Keywords:  Anastomotic leakage; LASSO; Prediction; Rectal cancer

Year:  2019        PMID: 31258603      PMCID: PMC6572974          DOI: 10.12669/pjms.35.3.252

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


INTRODUCTION

Rectal cancer is the third most common malignant tumor in the world. The incidence in China has been increasing at a rate of 4.2% per year.1 Surgery has been a common treatment approach for rectal cancer. But anastomotic leakage (AL) is one of the most frequent complications after the resection of rectal tumors. The incidence of postoperative AL in rectal cancer is 3%-13%.2,3 It can cause serious consequences such as pelvic abscesses, peritonitis, sepsis, septic shock and even death. Moreover, AL is also the main course of long-term complications such as postoperative anastomotic stenosis and bowel dysfunction. Although significant progress has been made in the stapler, operation technique and perioperative management in recent ten years, anastomotic leakage remains a major issue in clinical practice. Many factors4 are believed to affect the anastomosis, such as age, sex, level of anastomosis, ASA score, BMI, steroid treatment, preoperative chemoradiotherapy, tumor stage, tumor size, operative time, number of stapler firings, weight loss, malnutrition, fluid/electrolyte disorders, alcohol consumption, intra-operative transfusions/blood loss, smoking and diabetes but the pathogenesis remains unclear, which brings difficulties to accurately predict AL in rectal cancer. Thus colorectal surgeons may have to empirically use preventive colostomy for patients. In this study, we aimed to develop a risk model to predict the occurrence of postoperative AL and aid the proper selection of preventive ileostomy.

METHODS

This study was approved by the Institutional Review Board (IRB) of People’s Hospital of Longhua District (No. LW-20170301-003-01). The IRB waived the written informed consent from patients since this study was carried out retrospectively. Patients with rectal cancer who underwent surgical treatment in our hospital from 2010 to 2016 were enrolled. Rectal cancer was defined as a tumor located at 15 cm or less from the anal verge, as determined by endoscopy and/or digital rectal examination. The inclusion criteria were patients undergoing DIXON surgery without preventive colostomy.

Exclusion criteria were

Patients with colon cancer at the descending colon or above the descending colon Patients undergoing Miles surgery Patients undergoing Hartman surgery Patients undergoing transanal or transsacral local excision of rectal cancer. Finally, 188 patients were included, and amongst them 20 had postoperative anastomotic leakage. The diagnosis of AL was based on clinical manifestations and imaging results. For middle and low rectal cancer, the operation was strictly restricted to the procedure of total mesorectal excision (TME). Tumor-specific mesorectal excision (TSME) was performed for the upper rectal cancer and when the mesorectal excision level was 5 cm from the lower edge of the tumor.5,6 The mode of anastomosis includes stapled anastomosis and manual anastomosis. After the anastomosis, the leak test was performed. The conventional indwelling duration of drainage tube was 7-15 days.

Statistical analysis

Statistical analysis was conducted in R. Mean (standard deviation) and frequency (percentage) were summarized by anastomotic states for continuous and categorical variables, respectively. Chi-square tests or Fisher Exact tests were used for comparison of categorical variables and the Wilcoxon tests were used for comparison of real-value variables between the AL and non-AL groups. Half of the patients in each group were randomly selected as a training set to develop a prediction model with the LASSO method.7 The remaining cases were used as a validation set.

RESULTS

A total of 188 patients were included and 20 patients including 15 males and four females had postoperative AL with an incidence rate of 10.6%. The patient-related variables, tumor-related variables, and surgery-related variables were selected for univariate analysis (Table-I) and the degree of tumor differentiation, the distance between the lower edge of the tumor and the anal margin, anastomotic method, diabetes, intraoperative time, intraoperative bleeding and smoking history were significantly associated with AL (p <0.05).
Table-I

Univariate analysis of risk factors for anastomotic leakage.

VariableOverallNo Anastomotic Leak (n=168)Anastomotic Leak (n=20)P-value
Age61.11±14.0261.66(13.71)56.45(16.06)0.2152
Sex
 Female72(38.29)68(40.48)4(20)0.09
 Male116(61.70)100(59.52)16(80)
Preoperative chemoradiotherapy
 N174(92.55)156(92.86)18(90)0.648
 Y14(7.45)12(7.14)2(10)
Tumor size
 <4cm72(38.29)66(39.29)6(30)0.5726
 ≥4cm116(61.70)102(60.71)14(70)
Degree of tumor differentiation
 High differentiation11(5.85)7(4.17)4(20)8.24E-06
 Medium differentiation161(85.6)152(90.48)9(45)
 Low differentiation16(8.51)9(5.36)7(35)
Stage
 T1+T236(19.15)34(20.24)2(10)0.375
 T3+T4152(80.85)134(79.76)18(90)
TNM stage
 01(5)1(0.6)00.1422
 I30(15.96)29(17.26)1(5)
 II64(34.04)60(35.71)4(20)
 III81(43.09)67(39.88)14(70)
 IV12(6.38)11(6.55)1(5)
Lymph vascular invasion
 N97(51.60)88(52.38)9(45)0.6982
 Y91(48.40)80(47.62)11(55)
Distance
 <7cm51(27.13)38(22.62)13(65)0.0001674
 ≥7cm137(72.87)130(77.38)7(35)
Anastomotic method
 Hand-sewn3(1.60)1(0.6)2(10)0.03033
 Stapler185(98.40)167(99.40)18(90)
Diabetes
 N156(82.98)149(88.69)7(35)3.29E-07
 Y32(17.02)19(11.31)13(65)
Intraoperative time
 <3.5h136(72.34)127(75.60)9(45)0.006974
 ≥3.5h52(27.66)41(24.40)11(55)
Intraoperative bleeding
 <400ml170(90.43)162(96.43)8(40)6.34E-10
 ≥400ml18(9.57)6(3.57)12(60)
Smoking
 N146(77.66)138(82.14)8(40)0.0001219
 Y42(22.34)30(17.86)12(60)

Data are presented as mean ± SD or No. (%); Distance: distance between the lower edge of tumor and the anal margin

Univariate analysis of risk factors for anastomotic leakage. Data are presented as mean ± SD or No. (%); Distance: distance between the lower edge of tumor and the anal margin Then the factors including preoperative chemoradiotherapy, degree of tumor differentiation, anastomotic method, distance, intraoperative bleeding, smoking and diabetes were selected for multivariable analysis (Table-II). The significant risk factors for AL were preoperative chemoradiotherapy (p=0.04), medium degree of tumor differentiation (p=0.04), anastomotic method (p<0.01), intraoperative bleeding more than 400ml (p<0.01), smoking (p<0.01), and diabetes (p<0.01). The validation set was used to construct the ROC curve (Fig.1) and the area under the curve (AUC) of the ROC was 0.952, indicating a good performance of the prediction model.
Table-II

Multivariable analysis of risk factors for anastomotic leakage

FactorsORConfidence intervalP-value
Preoperative chemoradiotherapy (Y)21.018651.17~784.880.045
Degree of tumor differentiation (Medium)0.021.67E-04~0.720.040
Degree of tumor differentiation (Low)0.241.31E-03~20.630.542
Anastomotic method (Stapler)5.74E-046.36E-07~0.080.007
Distance(≥7cm)0.300.02~3.110.321
Intraoperative bleeding (≥400ml)124.3910.76~5403.720.001
Smoking (Y)179.8014.03~8337.25<0.001
Diabetes (Y)301.0223.70~1722.13<0.001
Fig.1

The ROC for occurrence of anastomotic leak prediction model.

Multivariable analysis of risk factors for anastomotic leakage The ROC for occurrence of anastomotic leak prediction model.

DISCUSSION

AL can potentially affect short period recurrences and long-term survival.8,9 Therefore, in this study, we aimed to develop a risk model to predict the occurrence of postoperative anastomotic leakage, to guide the surgeons to select the preventive ileostomy in a more scientific and standardized way. Despite the conspicuous progress in rectal cancer surgery, about 10.6% of the patients still have AL in our study, within the previously reported range of incidence rate (3%-13%). To select appropriate predictors, adaptive LASSO (least absolute shrinkage and selection operator) was used. LASSO method was originally developed for variable selection in building regression models and, Zou upgraded the LASSO to adaptive LASSO so that the selected model will be very close to the true models (Oracle property) as the sample size increases.7 The adaptive LASSO employs the appropriate penalty term to allow some of the coefficients to be estimated as zeros (variable exclusion) which is called sparsity regression. Unlike the stepwise regression using multiple steps and subjectively selected cutoff value of the p-value for exclusion, the selection of the predictors using adaptive LASSO is simultaneously achieved and the tuning parameter selection is data-driven. We found that preoperative chemoradiotherapy, diabetes, smoking, the amount of intraoperative bleeding, anastomotic method, and degree of tumor differentiation were independent AL risk factors after resection of rectal cancer. Consistently, preoperative chemoradiotherapy for rectal cancer has been previously reported as a risk factor for AL.10 The histological changes of blood vessels and epithelial tissue induced by preoperative chemoradiotherapy give rise to the destruction of mucosal inflammation and mucosal barriers,11 which may lead to mucosal atrophy, fibrosis of the intestinal wall and hardening of the blood vessels, making the use of the stapler difficult and increasing the incidence of AL. But future studies are still needed to investigate the impact of preoperative chemoradiotherapy on AL as some reports also show that preoperative chemoradiotherapy does not affect the technical feasibility of the stapler and does not significantly increase the morbidity of postoperative complications such as AL.12,13 Smoking has been reported to affect the healing of anastomotic stoma in gastrointestinal surgery.14 Nicotine affects arterial smooth muscle and slows blood flow. Inhalation of carbon monoxide combined with hemoglobin, resulting in the ability of blood to carry oxygen down, affecting blood coagulation and tissue remodeling. Smoking may change the use of Nitrous Oxide in the blood, and produce blood vessels destruction. In terms of the blood itself, smoking can cause changes in the function of the blood circulation system, cause insufficient blood supplied and impede the healing of the wound. On the other hand, smoking may alter the mechanism of inflammation, reduce the influx of macrophages in the inflammatory response, and reduce the formation of proinflammatory factors that control adhesion and migration. Vignali A et al.2 reported a correlation between diabetes mellitus and AL. Diabetic patients with systemic metabolic disorder and hyperglycemia lead to large amounts of reactive oxygen species (ROS) and advanced glycation end products (AGEs),15 which damage microvascular endothelial cells, resulting in abnormal flow of microvascular endothelial cells. Lipid metabolism and glucose metabolism disorder coexist in diabetic patients. The damage mechanism of lipotoxicity on microvascular endothelial cells is the increasing production of reactive oxygen species (ROS) caused by the up regulation of the expression level of the NADPH oxidase complex active functional subunit.16 The damage of the anastomotic microvessels hinders the healing of the anastomotic stoma. Hand-sewn was also found to be a risk factor of anastomotic leakage. There was significant difference (p < 0.05) in AL between stapled and hand-sewn colorectal anastomosis. A Cochrane review of colorectal anastomosis after right hemicolectomy showed that the total anastomotic leakage rate in the stapler group was significantly reduced.17 An interesting subgroup analysis conducted by Friend PJ et al.18 found that there was more anastomotic leakage in hand-sewn colorectal anastomosis when analysing the anastomosis alone. Their conclusion is that stapler anastomosis seems to be more suitable for surgeons without numerous surgical experience. The double stapling technique reduces the difficulty of the operation and reduces the difficulty of anastomosis due to the inconsistent caliber of the bowel lumen at both ends. Moreover, the design of the nail spacing, the row spacing and the varus degree of the intestinal wall by the stapler was more accurate and reasonable than manual suture. It can effectively avoid overflow of intestinal contents and reduce the chance of infection around the anastomotic stoma as well as the pelvic cavity. So the incidence of anastomotic leakage can be reduced. Wang L and Gu J19 reported the risk factor for symptomatic AL after anterior resection of low rectal cancer. Their results showed that blood loss more than 200 ml was identified as independent risk factors for AL. A systematic review by McDermott FD et al.20 showed that blood loss more than 100 ml was an independent risk factor for AL. In contract, Crombe T et al.21 reported that blood loss more than 500 ml did not significantly increase the risk of AL. In our study, intraoperative bleeding more than 400 ml was significantly associated with the increased risk of AL. This result suggests that prophylactic stoma should be considered when the amount of bleeding is large during the operation. Although there have been several studies22,23 reported that T staging is associated with the occurrence of AL, no studies have addressed the relationship between AL and the degree of tumor differentiation. Our study shows that the degree of tumor differentiation is also a risk factor of anastomotic leakage after anterior resection of rectal cancer. Low anastomosis is the most important risk factor for AL.24,25 In a previous study24, anal verge distance <7 cm was a risk factor associated with AL occurrence. A study conducted by Vignali A et al.2 showed that the incidence of anastomotic leakage was 8% when the lower edge of the tumor was within 7 cm from the anal margin, and when the tumor’s lower margin was more than 7 cm from the anal margin, it was 1%. Pakkastie TE et al.25 described similar results. They also determined the difference between high and low anastomosis at a distance of 7 cm from the edge of the anus. The high leakage rate associated with low anastomosis is probably due to the location of the tumor was lower, and that the free range of rectal surgery is greater, which increase the difficulty of the anastomosis with increased anastomotic tension and decrease the rectal blood supply. So it affects local healing and anti-infection ability, and increases the chance of bacterial infection, resulting in an increased chance of AL. However, our study found that Distance (≥7cm) was not protective factor for AL (p=0.32). Future studies are required to investigate feasibility of the selection of 7 cm as a cutoff point.

Limitations of study

This was a single center study, which result in sample bias. This prediction model could not define the actual situation of AL according to current risk factors. We expect that a prospective large-sample-size and multicenter study could be conducted in future to improve the reliability and practicability of the prediction model.

CONCLUSION

We have developed a model to predict AL after anterior rectal resection by using the LASSO method with an AUC 0.952. Preoperative chemoradiotherapy, diabetes, smoking, intraoperative bleeding, degree of tumor differentiation and method of anastomosis are independent risk factors for AL.

Author`s Contribution

SC conceived and designed the study. SC, BH and XZ did data collection and manuscript writing. SC and XZ did statistical analysis. SC, BH and XZ did review and final approval of manuscript.
  24 in total

1.  Stapling or suturing for anastomoses of the left side of the large intestine.

Authors:  P J Friend; R Scott; W G Everett; I H Scott
Journal:  Surg Gynecol Obstet       Date:  1990-11

2.  The impact of heavy smoking on anastomotic leakage and stricture after low anterior resection in rectal cancer patients.

Authors:  Min Jung Kim; Rumi Shin; Heung-Kwon Oh; Ji Won Park; Seung-Yong Jeong; Jae-Gahb Park
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

3.  Technical feasibility of laparoscopic total mesorectal excision for patients with low rectal cancer after concurrent radiation and chemotherapy with bevacizumab plus FOLFOX.

Authors:  Jin-Tung Liang; Hong-Shiee Lai; Kuo-Wei Cheng
Journal:  Surg Endosc       Date:  2010-06-05       Impact factor: 4.584

4.  Changing patterns of colorectal cancer in China over a period of 20 years.

Authors:  Ming Li; Jin Gu
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

5.  Risk factors for symptomatic anastomotic leakage after low anterior resection for rectal cancer with 30 Gy/10 f/2 w preoperative radiotherapy.

Authors:  Lin Wang; Jin Gu
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

6.  Risk factors for anastomotic leakage after rectal cancer resection and reconstruction with colorectostomy. A retrospective study with bootstrap analysis.

Authors:  Rene Warschkow; Thomas Steffen; Jutta Thierbach; Thomas Bruckner; Jochen Lange; Ignazio Tarantino
Journal:  Ann Surg Oncol       Date:  2011-04-06       Impact factor: 5.344

Review 7.  Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis.

Authors:  Alexander Mirnezami; Reza Mirnezami; Kandiah Chandrakumaran; Kishore Sasapu; Peter Sagar; Paul Finan
Journal:  Ann Surg       Date:  2011-05       Impact factor: 12.969

8.  Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications.

Authors:  G Valero; J A Luján; Q Hernández; M De Las Heras; E Pellicer; A Serrano; P Parrilla
Journal:  Int J Colorectal Dis       Date:  2003-07-15       Impact factor: 2.571

Review 9.  Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management.

Authors:  Martin Hauer-Jensen; Junru Wang; Marjan Boerma; Qiang Fu; James W Denham
Journal:  Curr Opin Support Palliat Care       Date:  2007-04       Impact factor: 2.302

Review 10.  Stapled versus handsewn methods for ileocolic anastomoses.

Authors:  P Y G Choy; I P Bissett; J G Docherty; B R Parry; A E H Merrie
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
View more
  2 in total

1.  Rectoseminal vesicle fistula after radical surgery for rectal cancer: Four case reports and a literature review.

Authors:  Zhi-Xiu Xia; Jin-Chun Cong; Hong Zhang
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

Review 2.  The influence of diabetes on postoperative complications following colorectal surgery.

Authors:  D J H Tan; C Y L Yaow; H T Mok; C H Ng; C H Tai; H Y Tham; F J Foo; C S Chong
Journal:  Tech Coloproctol       Date:  2021-01-01       Impact factor: 3.781

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.